Free Trial

Burning Rock Biotech (BNR) Competitors

Burning Rock Biotech logo
$3.30 +0.07 (+2.17%)
As of 12:34 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BNR vs. ATPC, SERA, KDLY, QIPT, PIII, OPGN, BDSX, BMGL, CCM, and MRAI

Should you be buying Burning Rock Biotech stock or one of its competitors? The main competitors of Burning Rock Biotech include Agape ATP (ATPC), Sera Prognostics (SERA), Kindly MD (KDLY), Quipt Home Medical (QIPT), P3 Health Partners (PIII), OpGen (OPGN), Biodesix (BDSX), Basel Medical Group (BMGL), Concord Medical Services (CCM), and Marpai (MRAI). These companies are all part of the "healthcare" industry.

Burning Rock Biotech vs.

Agape ATP (NASDAQ:ATPC) and Burning Rock Biotech (NASDAQ:BNR) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

0.0% of Agape ATP shares are owned by institutional investors. Comparatively, 30.0% of Burning Rock Biotech shares are owned by institutional investors. 9.7% of Agape ATP shares are owned by company insiders. Comparatively, 30.3% of Burning Rock Biotech shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Burning Rock Biotech's average media sentiment score of 0.00 beat Agape ATP's score of -0.47 indicating that Burning Rock Biotech is being referred to more favorably in the news media.

Company Overall Sentiment
Agape ATP Neutral
Burning Rock Biotech Neutral

Agape ATP has a beta of -0.55, indicating that its share price is 155% less volatile than the S&P 500. Comparatively, Burning Rock Biotech has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500.

Burning Rock Biotech received 5 more outperform votes than Agape ATP when rated by MarketBeat users. Likewise, 31.25% of users gave Burning Rock Biotech an outperform vote while only 0.00% of users gave Agape ATP an outperform vote.

CompanyUnderperformOutperform
Agape ATPOutperform Votes
No Votes
Underperform Votes
1
100.00%
Burning Rock BiotechOutperform Votes
5
31.25%
Underperform Votes
11
68.75%

Burning Rock Biotech has a net margin of -83.50% compared to Agape ATP's net margin of -194.09%. Burning Rock Biotech's return on equity of -60.68% beat Agape ATP's return on equity.

Company Net Margins Return on Equity Return on Assets
Agape ATP-194.09% -74.71% -56.08%
Burning Rock Biotech -83.50%-60.68%-42.30%

Agape ATP has higher earnings, but lower revenue than Burning Rock Biotech. Agape ATP is trading at a lower price-to-earnings ratio than Burning Rock Biotech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Agape ATP$1.29M81.63-$2.10M-$0.60-3.52
Burning Rock Biotech$515.82M0.07-$92.07M-$1.88-1.76

Summary

Burning Rock Biotech beats Agape ATP on 11 of the 14 factors compared between the two stocks.

Get Burning Rock Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for BNR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BNR vs. The Competition

MetricBurning Rock BiotechMedical laboratories IndustryBusiness SectorNASDAQ Exchange
Market Cap$35.51M$2.98B$24.20B$8.28B
Dividend YieldN/A31.23%2.48%4.10%
P/E Ratio-1.1013.8032.8619.58
Price / Sales0.07157.77271.45119.65
Price / CashN/A57.5630.9334.62
Price / Book0.314.205.354.47
Net Income-$92.07M-$22.21M$195.96M$248.22M
7 Day Performance15.79%-2.17%-1.46%-1.32%
1 Month Performance12.24%-1.62%15.14%10.73%
1 Year Performance-57.14%2.37%18.62%8.40%

Burning Rock Biotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BNR
Burning Rock Biotech
0.4509 of 5 stars
$3.30
+2.2%
N/A-56.2%$35.51M$515.82M-1.101,390Upcoming Earnings
Gap Down
ATPC
Agape ATP
0.4355 of 5 stars
$2.03
-1.0%
N/A-56.6%$101.51M$1.32M-2.7840Analyst Upgrade
Gap Down
SERA
Sera Prognostics
1.4844 of 5 stars
$2.32
+0.4%
N/A-77.1%$87.38M$115,000.00-2.34120Positive News
KDLY
Kindly MD
1.0545 of 5 stars
$13.96
+7.8%
N/AN/A$84.07M$2.47M-18.13N/AGap Up
QIPT
Quipt Home Medical
1.691 of 5 stars
$1.40
-1.1%
$2.85
+104.3%
-45.5%$60.11M$244.72M-8.21800Analyst Downgrade
PIII
P3 Health Partners
2.1904 of 5 stars
$7.94
-0.6%
$16.25
+104.7%
-69.7%$57.03M$1.50B-9.45500Gap Down
OPGN
OpGen
N/A$4.89
-0.2%
N/A+42.3%$49.23M$2.67M0.00100News Coverage
Analyst Forecast
BDSX
Biodesix
3.2758 of 5 stars
$0.30
-0.1%
$2.00
+564.5%
-76.6%$44.12M$71.32M-0.77220Analyst Forecast
High Trading Volume
BMGL
Basel Medical Group
N/A$2.13
-10.1%
N/AN/A$39.31M$10.05M0.0036News Coverage
CCM
Concord Medical Services
N/A$8.45
+0.5%
N/A+56.4%$36.69M$383.96M0.00970Gap Down
High Trading Volume
MRAI
Marpai
N/A$1.16
-3.9%
N/A-33.4%$17.32M$34.87M-0.44150Gap Down

Related Companies and Tools


This page (NASDAQ:BNR) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners